Real-world Effectiveness of Sarilumab in RA: Results from the Open-label, Prospective, Single-arm Observational PROFILE Study.

Alan J KivitzJacques Eric GottenbergMartin BergmanChunfu QiuHubert van HoogstratenRon de NijsLouis Bessette

Published in: Rheumatology and therapy (2024)

In this 1-year, observational real-world study, sarilumab therapy resulted in improved clinical outcomes. The safety profile was consistent with that observed in sarilumab randomized clinical trials. This study was entered on the German website (Paul Ehrlich Institute) on January 11, 2018, with NIS No.: 423.

Keyphrases

open label
randomized controlled trial
clinical trial
rheumatoid arthritis
radiation therapy
mesenchymal stem cells
study protocol
cell therapy
ankylosing spondylitis